Antibody-drug conjugates: Intellectual property considerations

Development of Novel ADCs: Conjugation of Tubulysin Analogues to Trastuzumab Monitored by Dual Radiolabeling

(2014) R. Cohen et al.   CANCER RESEARCH

Rituximab

(2014) Ulrich Storz   mAbs

Antibody-drug conjugates

(2013) Alain Beck et al.   mAbs

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis

(2013) Toshiyuki Minami et al.   Scientific Reports

Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases

(2012) Oran Erster et al.   JOURNAL OF CONTROLLED RELEASE

Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site

(2012) Thomas List et al.   mAbs

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

(2012) J. Y. Axup et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibody Conjugate Therapeutics: Challenges and Potential

(2011) B. A. Teicher et al.   CLINICAL CANCER RESEARCH